Cushing's Syndrome Terminated Phase 2 Trials for Mifepristone (DB00834)

Also known as: Cushing Syndrome / Cushing’s syndrome / Cushings syndrome / Syndrome Cushing's

IndicationStatusPhase
DBCOND0028130 (Cushing's Syndrome)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00422201Prospective, Open-Label, Multicenter, International Study of Mifepristone for Symptomatic Treatment of Cushing's Syndrome Caused by Ectopic Adrenal Corticotrophin Hormone (ACTH) SecretionTreatment